Production method of virus-inactivated plasma for treating COVID-19
The invention relates to a production method of virus-inactivated plasma for treating COVID-19. The method comprises the following steps: (1) collecting convalescent plasma of COVID-19 survivors or plasma immune to a Severe Acute Respiratory Syndrome Coronavirus 2 vaccine (SARS-CoV-2 vaccine), and conducting pretreatment; (2) adding methylene blue, and conducting photo-inactivation on the plasma;and (3) conducting labeling and packaging after the plasma passes tests..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Europäisches Patentamt - (2020) vom: 30. Juni Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
YANG XIAOMING [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-06-30, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 |
---|
Patentnummer: |
CN111346108 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA00546689X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA00546689X | ||
003 | DE-627 | ||
005 | 20230504130223.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210529s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA00546689X | ||
035 | |a (EPA)CN111346108 | ||
035 | |a (EPA)71193455 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a YANG XIAOMING |e verfasserin |4 aut | |
245 | 1 | 0 | |a Production method of virus-inactivated plasma for treating COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2020-06-30, Last update posted on www.tib.eu: 2022-04-09, Last updated: 2023-02-09 | ||
520 | |a The invention relates to a production method of virus-inactivated plasma for treating COVID-19. The method comprises the following steps: (1) collecting convalescent plasma of COVID-19 survivors or plasma immune to a Severe Acute Respiratory Syndrome Coronavirus 2 vaccine (SARS-CoV-2 vaccine), and conducting pretreatment; (2) adding methylene blue, and conducting photo-inactivation on the plasma;and (3) conducting labeling and packaging after the plasma passes tests. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a LI CESHENG |4 aut | |
700 | 0 | |a DUAN KAI |4 aut | |
700 | 0 | |a HE YANLIN |4 aut | |
700 | 0 | |a HU YONG |4 aut | |
700 | 0 | |a PENG YAN |4 aut | |
700 | 0 | |a ZHOU ZHIJUN |4 aut | |
700 | 0 | |a LIN LIANZHEN |4 aut | |
700 | 0 | |a YU JIANHONG |4 aut | |
700 | 0 | |a HAN REN |4 aut | |
700 | 0 | |a LIANG XIAOLONG |4 aut | |
700 | 0 | |a XING YANTAO |4 aut | |
700 | 0 | |a HOU YONG |4 aut | |
700 | 0 | |a LU ZHONGQUAN |4 aut | |
700 | 0 | |a DENG KUN |4 aut | |
700 | 0 | |a WANG YUE |4 aut | |
700 | 0 | |a GONG QIN |4 aut | |
700 | 0 | |a ZHENG XIAOBEI |4 aut | |
700 | 0 | |a LIU YING |4 aut | |
700 | 0 | |a ZHU CHEN |4 aut | |
700 | 0 | |a DENG ZHIJUN |4 aut | |
700 | 0 | |a ZOU HAOYONG |4 aut | |
700 | 0 | |a JIA LING |4 aut | |
700 | 0 | |a LIU ZHIPENG |4 aut | |
700 | 0 | |a LIU CHUNJIE |4 aut | |
700 | 0 | |a SI SHIHONG |4 aut | |
700 | 0 | |a PAN XIAOMING |4 aut | |
700 | 0 | |a FENG LU |4 aut | |
700 | 0 | |a ZHAN QIAN |4 aut | |
700 | 0 | |a CHEN KEJIN |4 aut | |
700 | 0 | |a LI TAOJING |4 aut | |
700 | 0 | |a YUE SHENGLAN |4 aut | |
700 | 0 | |a WU XIAO |4 aut | |
700 | 0 | |a XIE YONG |4 aut | |
700 | 0 | |a YU DING |4 aut | |
700 | 0 | |a ZHOU DONGBO |4 aut | |
700 | 0 | |a YANG HUICHUAN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 30. Juni |
773 | 1 | 8 | |g year:2020 |g day:30 |g month:06 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71193455/publication/CN111346108A1?q=CN111346108 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2020 |b 30 |c 06 |
951 | |a AR | ||
952 | |j 2020 |b 30 |c 06 |